ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6676
Avg. Estimate-1.24-1.31-4.32-4.61
Low Estimate-1.39-1.51-4.79-6.13
High Estimate-0.78-0.93-3.58-1.56
Year Ago EPS-1.21-1.07-4.26-4.32
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts5676
Avg. Estimate100k320k1.4M2.06M
Low EstimateN/AN/AN/AN/A
High Estimate230k1.41M5.79M11.59M
Year Ago Sales502.96k324.49k1.77M1.4M
Sales Growth (year/est)-80.10%-1.40%-21.00%47.10%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.85-0.93-0.89-1.05
EPS Actual-1.21-1.07-1.24-0.64
Difference-0.36-0.14-0.350.41
Surprise %-42.40%-15.10%-39.30%39.00%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-1.24-1.31-4.32-4.61
7 Days Ago-1.22-1.3-4.29-4.58
30 Days Ago-1.2-1.27-4.35-4.73
60 Days Ago-1.07-1.11-4.36-4.46
90 Days Ago-1.1-1.13-4.53-4.53
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesASNDIndustrySectorS&P 500
Current Qtr.-2.50%N/AN/A0.48
Next Qtr.-22.40%N/AN/A0.40
Current Year-1.40%N/AN/A0.21
Next Year-6.70%N/AN/A0.10
Next 5 Years (per annum)24.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A